Global asthma market to reach 159 million lifetime cases by 2022 – The Pharma Letter

Global asthma market to reach 159 million lifetime cases by 2022
The Pharma Letter
Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion. While drugs to manage asthma have existed for several decades, pharmaceutical companies have developed faster acting and more effective products over 

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.